Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
05/2010
05/06/2010WO2010049768A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
05/06/2010WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
05/06/2010WO2009034582A3 Process for the preparation of amorphous fexofenadine hydrochloride
05/06/2010US20100113793 Process for the Preparation of Highly Pure Donepezil
05/06/2010US20100113792 Benzylpiperizine compound
05/06/2010US20100113791 Preparation of precursors of carbenes of caac type and preparing said carbenes therefrom
05/06/2010US20100113770 O-substituted hydroxyaryl derivatives
05/06/2010US20100113722 Sulfur chelated ruthenium compounds useful as olefin metathesis catalysts
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113519 1,5-Dideoxy-1,5-imino-D-glucitol Compounds
05/06/2010US20100113511 Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
05/06/2010US20100113496 Piperidine modulators of vmat2
05/06/2010CA2779178A1 Analgesic that binds filamin a
05/06/2010CA2741658A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010CA2741517A1 Thyroid receptor ligands
05/06/2010CA2741433A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
05/05/2010EP2181093A2 Immobilization of dyes and antimicrobial agents on a medical device
05/05/2010EP1987001B1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
05/05/2010EP1569929B1 Compounds and methods for the treatment or prevention of flavivirus infections
05/05/2010CN1630629B 酯化合物及其医药用途 Ester compounds and pharmaceutical use
05/04/2010USRE41315 Modulators of dopamine neurotransmission
05/04/2010US7709641 Neurokinin-1, substance P (NK1); serotonin reuptake inhibitors; for treating emesis, depression, anxiety and cough
05/04/2010US7709500 Chemical compounds
05/04/2010CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
05/04/2010CA2312087C Preparation comprising sterically hindered amines for the prevention and treatment of inflammation
04/2010
04/29/2010US20100105917 Method for producing optically active 3-aminopiperidine or salt thereof
04/29/2010US20100105916 Processes for Preparing Donepezil
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105736 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
04/29/2010US20100105731 Novel benzamidine compound
04/29/2010US20100105730 Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine
04/29/2010US20100105686 Phenylsulfamoyl benzamide derivatives as bradykinin antagonists
04/29/2010US20100104979 Alpha-hydroxyketones
04/29/2010DE102008053240A1 Herstellung von (N-Heterozyklyl)-Arylethern Preparation of (N-heterocyclyl) -Arylethern
04/28/2010EP2179988A1 Producing (N-heterocyclic) aryl ethers
04/28/2010EP2179984A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
04/28/2010EP2178879A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
04/28/2010EP2178858A1 Novel heterocyclic compounds as mglu5 antagonists
04/28/2010EP2178835A1 Novel substituted piperidones as hsp inducers
04/28/2010EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof
04/28/2010CN1747929B Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
04/28/2010CN1658855B O-substituted hydroxyaryl derivatives
04/28/2010CN101698658A Method for preparing wormer sec-Butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate
04/27/2010US7705153 chemokine coupled receptor 3 (CCR3); treating asthma; 1-(heteroarylcarbonyl)-4-piperidino-piperidine compounds
04/27/2010US7705011 Agent for treatment and prevention of endometriosos and uterine adenomyosis
04/27/2010US7704543 Obtaining a high density, reproducible and uniform coverage of a solid surface suitable for solid state synthesis and biosynthesis; aminosilanation of activated glass reacted with a diester of trimesic acid and N-hydroxysuccinimide followed by hydrolysis; attaching of DNA, proteins, biopolymers
04/22/2010WO2010043584A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
04/22/2010US20100099915 Process of making alpha-aminooxyketone/alpha-aminooxyaldehyde and alpha-hydroxyketone/alpha-hydroxyaldehyde compounds and a process making reaction products from cyclic alpha, beta-unsaturated ketone substrates and nitroso substrates
04/22/2010US20100099880 Alternate Process for Remifentanil Preparation
04/22/2010US20100099710 Src family kinase inhibitors
04/22/2010US20100099703 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments
04/22/2010CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
04/21/2010EP2177518A1 Organic compounds
04/21/2010EP2176223A1 Malonamide derivatives with antithrombotic activity
04/21/2010EP1761494B1 Chemical compounds i
04/21/2010EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists
04/21/2010EP0888303B1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
04/21/2010CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors
04/21/2010CN101696187A Synthesizing method of N-substituent-1,2,3,6-tetrahydropyridine
04/21/2010CN101696186A Method for synthesizing 1-deoxynojirimycin derivative
04/20/2010US7700794 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
04/20/2010US7700780 Zwitterionic chromophores and macromolecules containing such chromophores
04/20/2010US7700779 Crystalline forms of fexofenadine and its hydrochloride
04/20/2010US7700778 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/20/2010US7700777 Crystalline forms of a biphenyl compound
04/20/2010US7700632 3-(3-Chloro-biphenyl-4-yloxymethyl)-benzoic acid; antidiabetic; type 2 diabetes, insulin resistance, impaired glucose tolerance, obesity
04/20/2010US7700629 Use of a non-racemic mixture of bupivacaine enantiomers, for improving the anesthesia profile
04/20/2010US7700625 Hydroxybenzamide derivatives and their use as inhibitors of Hsp90
04/20/2010US7700624 To treat inflammatory diseases, immune diseases and cancer; 4-{[(1R3S)-3-isopropyl-3-({4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}carbonyl)cyclopentyl]amino}-1-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexanol; side effect reduction; improved long term safety profile; oral administration; half life
04/20/2010US7700623 Arylamidine derivative, salt thereof, and antifungal containing these
04/20/2010US7700622 Antiinflammatory agents; autoimmune disease; bone disorders; viricides; antiproliferative agents; antiarthritic agents
04/20/2010US7700587 Haloperidol analogs
04/20/2010US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
04/20/2010CA2434370C Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith
04/20/2010CA2418744C Novel aminocyclohexane derivatives
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/20/2010CA2319680C Compounds and compositions for delivering active agents
04/20/2010CA2279331C Compounds and compositions for delivering active agents
04/15/2010WO2010042867A2 Activators of human pyruvate kinase
04/15/2010WO2010042788A1 Method of inducing negative chemotaxis
04/15/2010WO2009125434A3 Oxime derivatives, process for their preparation, pharmaceutical composition containing the same and medicinal use thereof
04/15/2010US20100094015 Indazole having analgesic activity
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093801 Piperidine compounds, pharmaceutical composition comprising the same and its use
04/15/2010US20100093798 Cyclic modulators of chemokine receptor activity
04/15/2010US20100093797 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
04/15/2010US20100093753 Biphenyl compounds useful as muscarinic receptor antagonists
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093706 Multimediator transporter inhibitors for use in treatment of central nervous system disorders
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010CA2740148A1 Activators of human pyruvate kinase
04/15/2010CA2740099A1 Method of inducing negative chemotaxis
04/14/2010EP2174930A1 Antitumor agent comprising sulfostin and sulfostin-related compound as the active ingredient
04/14/2010EP2174659A1 Substituted indeno[1,2-c]isoquinoline derivatives and uses thereof
04/14/2010EP2173715A2 Use of piperidine derivatives as agonists of chemokine receptor activity
04/14/2010EP2173714A1 Piperidine derivatives as modulators of chemokine receptor activity
04/14/2010EP2173713A2 Piperidinyl derivatives as modulators of chemokine receptor activity
04/14/2010EP2173712A2 Indane-amine derivatives, their preparation and use as medicaments
04/14/2010EP2173707A1 Pleuromutilin derivatives and their use as antimicrobials
04/14/2010EP1704146B1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 380